Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EXPH5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NGLY1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101928615 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMAD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RRP12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF791 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C19orf12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD20A5P - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
PLOD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLCO3A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
THUMPD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NCOA4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR77 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YIF1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPI - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR7112 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC4A7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EXOSC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DCC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PROS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on